Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
about
alpha-Synuclein and neuronal cell deathProteome analysis of human substantia nigra in Parkinson's diseaseSulforaphane as a potential protective phytochemical against neurodegenerative diseasesConformational equilibria in monomeric alpha-synuclein at the single-molecule levelStructures of the E46K mutant-type α-synuclein protein and impact of E46K mutation on the structures of the wild-type α-synuclein proteinParkinson's disease: from monogenic forms to genetic susceptibility factorsThe synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementiaGenetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation updateParkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerizationMagnesium inhibits spontaneous and iron-induced aggregation of alpha-synucleinSynphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synucleinA product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell deathDequalinium-induced protofibril formation of alpha-synucleinLeucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicitySynaptic vesicle trafficking and Parkinson's diseaseParkin accumulation in aggresomes due to proteasome impairmentParkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitroAlpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recyclingFK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53TMolecular determinants of α-synuclein mutants' oligomerization and membrane interactionsSynphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patientsEvidence that alpha-synuclein does not inhibit phospholipase Dc-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's diseasep25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathiesChromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics StudyThe synucleinsMisfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathiesGenetics of Parkinson diseaseGenome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson diseaseAutoproteolytic fragments are intermediates in the oligomerization/aggregation of the Parkinson's disease protein alpha-synuclein as revealed by ion mobility mass spectrometryα-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced deathSecondary structure and dynamics of micelle bound beta- and gamma-synucleinProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesalpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodiesResidual structure, backbone dynamics, and interactions within the synuclein familyNUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
P2860
Q21202835-035F9F60-94BD-45E5-8593-2168DEF9C6BAQ21245637-CD0FC160-0831-4D1B-BBA5-AC7B68495604Q21285068-CF350768-1EC9-4C1A-A959-1A6B235DC55FQ21563559-1B3F4BC0-CF55-42C6-AADD-6D33091E8717Q22061749-C8A810EC-CABA-4A4F-A740-6E4A71BD7CFFQ22242870-3D00FFCE-FD7B-4629-A3F3-79F63DE135CBQ22252705-7E9A722E-02EE-4120-91F9-DACFD5E52F19Q22252904-A956B8D5-B499-4337-8E9A-FA816F0E5314Q24290518-4FE07E2F-0753-446D-A521-8386E4DE22F6Q24291150-49115E3B-3A49-455C-B7CE-96153C8232D2Q24292317-17B0BF83-E378-4D42-9114-4EB544E9853EQ24294532-DCC59E7B-FFF1-4ECF-8BDC-B9BD9A30BD8AQ24297163-EE5A8845-D288-46E9-B450-0C4F1CC0D618Q24298122-9BE8DE2A-955C-41E9-8BCC-DA6827159D92Q24298689-C2D62D53-15E9-4411-9DBF-3C3CEC2AD7A3Q24301946-E6ED4C75-BE26-48E7-BA56-8F4EECE7BC13Q24302024-0A9F1E30-0044-4C3B-96E9-0A5C14F4B627Q24308757-F8DDB0A5-A0DF-456C-8E21-DF48D9EE6189Q24311461-67211E93-ACC9-4452-A558-25FEA9951D6CQ24311523-33FE4CB0-4FDF-4E55-9B77-1C5E60A1EC7EQ24311758-3B15B5AB-3DD9-41D5-9D11-7E4F0B8FC1F2Q24312185-A6A61476-6AE7-42EC-B4CB-D9259543BD2EQ24314275-E13A9A3E-04FF-44A0-A9FB-C726DBC9923BQ24316900-C9BD6FED-4A5B-4ED8-A8B7-1073095C5820Q24318974-F7E7F7D0-FD73-4554-BB45-3997E7C9AAB5Q24320549-BDACA2C4-2280-4D68-AC21-BF9CEB2E827EQ24539105-BBEFD034-4D54-4E00-8B6E-0425EBA5DA6BQ24551013-D62FC5B4-7EF3-4323-909D-DA4E0482D039Q24554351-9A260B70-36A7-44C1-9108-FD370C60ED8FQ24558967-13305A01-1F36-4557-8F6A-3C81683FB806Q24596763-C2DE8CA5-5111-40AD-A254-F879BB7E9E76Q24632795-11C2E81C-938B-4281-A139-7DFA61C3BE7EQ24633663-EB678024-FD06-4519-BF8F-D9DE43B8FA96Q24644712-75C3B042-36A1-4003-8632-95B4BE7F95D1Q24647859-5F516703-AD99-4236-AFC6-312BCF8FD0E1Q24650014-92F6AC19-655E-4580-B15D-E57E781347DBQ24653247-79180995-A086-4469-8AAA-93A3931886BBQ24671058-6E07E393-3EE8-40EA-AFDD-E3E8561B2477Q24671360-7044768A-318B-4C10-B192-84B67E932A43Q24683059-1A62EE73-C69A-428A-8808-710AC89FD5BF
P2860
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
@ast
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
@en
type
label
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
@ast
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
@en
altLabel
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
@en
prefLabel
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
@ast
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
@en
P2093
P2860
P3181
P356
P1433
P1476
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
@en
P2093
Przuntek H
Woitalla D
P2860
P2888
P3181
P356
10.1038/NG0298-106
P407
P577
1998-02-01T00:00:00Z
P6179
1011429868